페이지 정보
본문
In the presence of sexual stimulation, nitric oxide is released in the corpus cavernosum, part of the penis, which activates the enzyme guanylate cyclase. By inhibiting PDE5, viagra red face enhances the effect of nitric oxide and cGMP, can you buy doxycycline over the counter in canada leading to improved erectile function. The mechanism by which Viagra operates is through the inhibition of phosphodiesterase-5 (PDE5), an enzyme that promotes the breakdown of cyclic guanosine monophosphate (cGMP). This enzyme increases levels of cGMP, leading to smooth muscle relaxation and inflow of blood to the penile tissues, thereby producing an erection.
Viagra, chemically known as sildenafil citrate, was initially developed for the treatment of hypertension and angina pectoris, a type of chest pain associated with coronary heart disease. However, during clinical trials in the early 1990s, an unexpected property of Viagra emerged—it significantly improved erectile function. Food and Drug Administration (FDA) in 1998 as the first oral treatment for erectile dysfunction (ED). This serendipitous discovery led to its approval by the U.S.
It has shown potential in treating pulmonary arterial hypertension (PAH), a rare but serious disease that affects the blood vessels in the lungs. Research is ongoing into other possible therapeutic uses, including its effects on heart disease, diabetes-induced kidney damage, and even certain types of cancer. For this indication, the drug is marketed under the name Revatio. Beyond its use in erectile dysfunction, Viagra has also been explored for other medical conditions.
For instance, it has shown potential benefits in treating pulmonary arterial hypertension (PAH), a serious condition characterized by high blood pressure in the arteries of the lungs. In addition to its primary use in erectile dysfunction, Viagra has also been explored for other medical conditions. Sildenafil, under the brand name Revatio, is approved for the treatment of PAH, where it works by relaxing blood vessels in the lungs to allow blood to flow more easily.
Viagra works by inhibiting an enzyme known as phosphodiesterase type 5 (PDE5), which is responsible for the breakdown of cGMP in the corpus cavernosum. By blocking PDE5, Viagra enhances the effects of NO by prolonging the duration and effect of cGMP, thus improving the ability to achieve and maintain an erection in the presence of sexual stimulation. In conclusion, Viagra has made a significant impact on the treatment of erectile dysfunction since its introduction.
Its discovery has not only provided a highly effective treatment option for millions of men with ED but has also opened new avenues of research into the use of PDE5 inhibitors for other medical conditions. As research continues, the scope of Viagra's impact on medicine may expand even further. It is effective in various populations of men with ED, including those with diabetes mellitus, spinal cord injury, and other conditions. The clinical efficacy of Viagra has been demonstrated in numerous studies.
Typically, Viagra is taken about one hour before sexual activity, and its effects can last for up to four hours. However, the effectiveness of Viagra can be influenced by certain factors such as the presence of food in the stomach, particularly high-fat meals, which can delay the onset of action.
Viagra, chemically known as sildenafil citrate, was initially developed for the treatment of hypertension and angina pectoris, a type of chest pain associated with coronary heart disease. However, during clinical trials in the early 1990s, an unexpected property of Viagra emerged—it significantly improved erectile function. Food and Drug Administration (FDA) in 1998 as the first oral treatment for erectile dysfunction (ED). This serendipitous discovery led to its approval by the U.S.
It has shown potential in treating pulmonary arterial hypertension (PAH), a rare but serious disease that affects the blood vessels in the lungs. Research is ongoing into other possible therapeutic uses, including its effects on heart disease, diabetes-induced kidney damage, and even certain types of cancer. For this indication, the drug is marketed under the name Revatio. Beyond its use in erectile dysfunction, Viagra has also been explored for other medical conditions.
For instance, it has shown potential benefits in treating pulmonary arterial hypertension (PAH), a serious condition characterized by high blood pressure in the arteries of the lungs. In addition to its primary use in erectile dysfunction, Viagra has also been explored for other medical conditions. Sildenafil, under the brand name Revatio, is approved for the treatment of PAH, where it works by relaxing blood vessels in the lungs to allow blood to flow more easily.
Viagra works by inhibiting an enzyme known as phosphodiesterase type 5 (PDE5), which is responsible for the breakdown of cGMP in the corpus cavernosum. By blocking PDE5, Viagra enhances the effects of NO by prolonging the duration and effect of cGMP, thus improving the ability to achieve and maintain an erection in the presence of sexual stimulation. In conclusion, Viagra has made a significant impact on the treatment of erectile dysfunction since its introduction.
Its discovery has not only provided a highly effective treatment option for millions of men with ED but has also opened new avenues of research into the use of PDE5 inhibitors for other medical conditions. As research continues, the scope of Viagra's impact on medicine may expand even further. It is effective in various populations of men with ED, including those with diabetes mellitus, spinal cord injury, and other conditions. The clinical efficacy of Viagra has been demonstrated in numerous studies.
Typically, Viagra is taken about one hour before sexual activity, and its effects can last for up to four hours. However, the effectiveness of Viagra can be influenced by certain factors such as the presence of food in the stomach, particularly high-fat meals, which can delay the onset of action.
댓글목록
등록된 댓글이 없습니다.